Call for papers: Biotechnology Investing
The Journal of Commercial Biotechnology is looking for papers on investing strategies in the biotechnology space. The scope can include […]
The Journal of Commercial Biotechnology is looking for papers on investing strategies in the biotechnology space. The scope can include […]
For those attending BIO2008 in San Diego this year, I’ll be doing a signing of my books on Wednesday June
I’ve nearly completed revisions for the third edition of Building Biotechnology, the leading textbook on the business of biotechnology. This
Seeking reviewers and contributors for next edition of Building Biotechnology Read Post »
The science of biotechnology is tough. R&D can be unpredictable, and most products need regulatory approval before they can be
Dyadic founder fights to regain control of company Read Post »
Apologies for light posting as of late. I’ve been buried deep in revisions to Building Biotechnology and prepping for an
The March 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to
Journal of Commercial Biotechnology — March 2008 Read Post »
Posting has been light lately — I’ve been working hard on revising Building Biotechnology. Off to the NIH next week
Two new biotechnology books: I’m proud to announce two new books featuring international best practices in biotechnology business development and
Guest content from John Avellanet, managing director and principal of Cerulean Associates: Follow-on biologics are a foregone conclusion in the
Browsing around the Biotechnology Industry Organization site late last night, I was surprised to find that BIO’s press release section
Get new actionable insights and updates from BiotechBlog